Association between telomere length and clinical indices in patients with idiopathic pulmonary fibrosis
Not Applicable
Recruiting
- Conditions
- Idiopathic pulmonary fibrosis (IPF)
- Registration Number
- JPRN-UMIN000024289
- Lead Sponsor
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
(A)Retrospective study; patients who experienced the onset of malignant disease within 3 years from first visit for our hospital. (B)Prospective study; (1) Patients with complication of malignant disease. But the patients who received complete resection or successful remission induction, and survived for more than 3 years without evidence of recurrence are eligible. (2) Patients who have been received more than 10mg/day of prednisolone or antifibrotic agents within 6 months. (3) Patients with acute exacerbation of IPF, respiratory infection, or pneumothorax within 4 weeks.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the telomere length attrition rate by administration of antifibrotic agent.
- Secondary Outcome Measures
Name Time Method